Abbott Laboratories (ABT) Interest Expenses (2016 - 2025)
Abbott Laboratories (ABT) has disclosed Interest Expenses for 17 consecutive years, with $120.0 million as the latest value for Q4 2025.
- Quarterly Interest Expenses fell 11.76% to $120.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $493.0 million through Dec 2025, down 11.81% year-over-year, with the annual reading at $493.0 million for FY2025, 11.81% down from the prior year.
- Interest Expenses hit $120.0 million in Q4 2025 for Abbott Laboratories, down from $121.0 million in the prior quarter.
- In the past five years, Interest Expenses ranged from a high of $166.0 million in Q3 2023 to a low of $120.0 million in Q4 2025.
- Historically, Interest Expenses has averaged $139.0 million across 5 years, with a median of $135.5 million in 2021.
- Biggest five-year swings in Interest Expenses: increased 20.45% in 2023 and later dropped 14.79% in 2025.
- Year by year, Interest Expenses stood at $131.0 million in 2021, then rose by 17.56% to $154.0 million in 2022, then grew by 3.25% to $159.0 million in 2023, then fell by 14.47% to $136.0 million in 2024, then dropped by 11.76% to $120.0 million in 2025.
- Business Quant data shows Interest Expenses for ABT at $120.0 million in Q4 2025, $121.0 million in Q3 2025, and $121.0 million in Q2 2025.